Nicotinamide Treatment for Stem Cell Homing and Engraftment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for enhancing the homing, retention, and engraftment of transplanted cells, such as hepatocytes and neural cells, are only marginally effective, with a significant portion of transplanted cells being cleared from the body without localizing to target organs or tissues, necessitating improved strategies for cell migration and integration.
Innovation Solution
Exposure of cells to nicotinamide for a specific period to down-regulate CD26 expression, enhancing cell homing and engraftment potential by increasing the functionality of adhesion and integrin molecules, thereby improving cell migration and retention in target tissues.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods are used for cell transplantation, then the procedure is simple, but the homing and engraftment efficiency of transplanted cells is low
Solution Approach 1:
The patent applies preliminary action by treating cells with nicotinamide ex-vivo before transplantation to down-regulate CD26 expression and enhance homing capability. This preparatory treatment ensures that when cells are transplanted, they already possess improved migratory properties, resolving the contradiction between simple procedure and low efficiency by embedding the enhancement step in the cell preparation phase rather than requiring complex in-vivo interventions.
Solution Approach 2:
The patent changes the biochemical parameter of cell surface CD26 expression through nicotinamide treatment. By modifying this specific molecular parameter, the cells' ability to respond to chemokine gradients and home to target tissues is enhanced, thereby improving engraftment efficiency without complicating the overall transplantation procedure.
2Reliability
If cell treatment methods are applied to improve homing, then engraftment efficiency increases, but treatment time and processing requirements increase
Solution Approach 1:
The patent applies partial action by using a short-duration nicotinamide treatment protocol that is sufficient to down-regulate CD26 expression and enhance homing, but not excessively long to cause unnecessary delays. This optimized treatment window balances the need for improved engraftment efficiency with the constraint of minimizing processing time, allowing clinical workflows to be maintained while achieving better outcomes.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Nicotinamide treatment significantly enhances the homing and engraftment of cells, as demonstrated by increased CD26 down-regulation, improved migration, and increased repopulation of cells in target tissues, leading to effective cell transplantation and tissue regeneration.
Implementation Method 1
Exposure of cells to nicotinamide for a specific period to down-regulate CD26 expression, enhancing cell homing and engraftment potential
Implementation Method 2
increasing the functionality of adhesion and integrin molecules, thereby improving cell migration and retention in target tissues
Data Source
AI summary
A method of enhancing cell engraftment potential is provided. The method comprising ex-vivo or in-vitro subjecting a population of cells to an amount of nicotinamide for a period of time sufficient to effect the population of cells, thereby enhancing cell engraftment potential.